Skip to main content
Addex Therapeutics Ltd (SWX: ADXN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
0.0598
-0.0020 (-3.24%)
Nov 19, 2024, 3:26 PM CET

Addex Therapeutics Revenue

Addex Therapeutics had revenue of 115.28K CHF in the quarter ending June 30, 2024, a decrease of -81.76%. This brings the company's revenue in the last twelve months to 863.23K, down -59.82% year-over-year. In the year 2023, Addex Therapeutics had annual revenue of 1.65M with 13.99% growth.

Revenue (ttm)
863.23K
Revenue Growth
-59.82%
P/S Ratio
6.23
Revenue / Employee
37.53K
Employees
23
Market Cap
5.88M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.65M202.11K13.99%
Dec 31, 20221.44M-1.71M-54.18%
Dec 31, 20213.15M-725.84K-18.71%
Dec 31, 20203.88M1.05M36.89%
Dec 31, 20192.83M-3.87M-57.72%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Roche Holding AG 60.58B
Roche Holding AG 60.58B
Novartis AG 42.18B
Lonza Group AG 6.70B
Galderma Group AG 3.88B
Sonova Holding AG 3.63B
Straumann Holding AG 2.54B
Ypsomed Holding AG 617.07M
Revenue Rankings

Addex Therapeutics News

More News